Pantoprazole sodium and Social avoidant behavior - a phase IV clinical study of FDA data

Summary:

Social avoidant behavior is reported as a side effect among people who take Pantoprazole sodium (pantoprazole sodium), especially for people who are female, 60+ old, also take Folic Acid, and have Depression.

The phase IV clinical study analyzes which people have Social avoidant behavior when taking Pantoprazole sodium. It is created by eHealthMe based on reports of 66,361 people who have side effects when taking Pantoprazole sodium from the FDA, and is updated regularly.

What is Pantoprazole sodium?

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 66,891 Pantoprazole sodium users. Check the latest studies of Pantoprazole sodium.

What is Social avoidant behavior?

Social avoidant behavior is found to be associated with 476 drugs and 618 conditions by eHealthMe. Check the latest studies of Social avoidant behavior.

On Jul, 19, 2026

66,361 people reported to have side effects when taking Pantoprazole sodium.
Among them, 11 people (0.02%) have Social avoidant behavior.

Could Pantoprazole sodium cause Social avoidant behavior?

Among these 11 people:

What is the gender of people who have Social avoidant behavior when taking Pantoprazole sodium? *

female: 100 %
male: 0.0 %

What is the age of people who have Social avoidant behavior when taking Pantoprazole sodium? *

What are other drugs people take besides Pantoprazole sodium? *

What are other side effects people have besides Social avoidant behavior? *

Depression: 4 people, 36.36%
Nausea And Vomiting: 4 people, 36.36%
Weight Decreased: 4 people, 36.36%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 36.36%
Hyperhidrosis (abnormally increased sweating): 4 people, 36.36%
Diarrhea: 3 people, 27.27%
Dyspnea (difficult or laboured breathing): 3 people, 27.27%
Blood Creatinine Increased: 2 people, 18.18%
Chills (felling of cold): 2 people, 18.18%
Irritability: 2 people, 18.18%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
Depression: 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 9.09%
Asthma: 1 person, 9.09%
Bipolar Disorder (mood disorder): 1 person, 9.09%
Blood Glucose Abnormal: 1 person, 9.09%
Diabetes: 1 person, 9.09%
Drowsiness: 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole sodium and have Social avoidant behavior?

- Check whether Social avoidant behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pantoprazole sodium:

Pantoprazole sodium (66,891 reports)

Browse all side effects of Pantoprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Social avoidant behavior:

Social avoidant behavior (476 drugs)

Browse all the conditions that are associated with Social avoidant behavior:

Social avoidant behavior (618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium (the active ingredients of Pantoprazole sodium) and Pantoprazole sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.